NDC 33342-093
rizatriptan benzoate 5 mg tablet, orally disintegrating
On the label: Macleods Pharmaceuticals Limited.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Macleods Pharmaceuticals Limited | District Solan, India | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyOct 20, 2023 · 6 inspections, 2 with FDA action |
Recalls
- Oct 18, 2021 · Class III · Macleods Pharma Usa, Inc
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Lots: Lot #: BRL2102A, BRL2103A, exp. date 04/2025 - Oct 18, 2021 · Class III · Macleods Pharma Usa, Inc
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Lots: Lot #: BRM2111A, BRM2112A, BRM2113A, BRM2114A, BRM2115A, BRM2116A, exp. date 04/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Rizatriptan: every company that makes it
- Form
- tablet, orally disintegrating, oral
- Strength
- 5 mg
- Approval
- ANDA ANDA203146
- On the market since
- Sep 23, 2014
- Package NDCs
33342-093-0433342-093-0733342-093-1233342-093-2333342-093-4133342-093-4533342-093-4633342-093-4833342-093-5233342-093-7233342-093-73- Official label
- DailyMed (National Library of Medicine), updated Feb 27, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?